Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)Wen Xu, Jianping Weng, Zilin Sun et al.|Journal of Internal Medicine|2014Cited by 59
GLP-1 receptor agonist protects glucose-stimulated insulin secretion in pancreatic β-cells against lipotoxicity via PPARδ/UCP2 pathwayZhigu Liu, Wen Xu|Cellular and Molecular Life Sciences|2025Cited by 5